Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Infotagion Readers Now Over 2 million

21 Apr 2020 14:00

RNS Number : 3792K
Iconic Labs PLC
21 April 2020
 

 

 

21st April 2020

 

 

Iconic Labs Plc ("Iconic Labs" or the "Company")

Infotagion Readers Now Over 2 million as they announce major partnership with M&C Saatchi and launch of new podcast

 

• Announcement of new partnership with award winning advertising agency M&C Saatchi

• Infotagion has now reached over 2 million people through more than 87 pieces of news

• Launch of weekly podcast featuring Damian Collins MP, Iconic Labs and key media influencers

• In negotiation with several world leading Universities about using platform and data

Iconic Labs Plc (LSE:ICON) (the "Company"), a multi-divisional new media and technology business, announces a new partnership with the award winning advertising agency, M&C Saatchi after the successful launch of Infotagion which has now reached over 2 million readers - doubling the reach from launch. 

Infotagion were approached by M&C Saatchi to work together on a pro bono (unpaid) basis. M&C Saatchi is launching, through Infotagion, 'Find the Truth. Isolate the Lies', a mythbusting campaign that will expose the most dangerous lies circulating about Covid-19 and reveal new ones as they arise. The free service is managed by the founders of Iconic Labs who are leading the direction, distribution and amplification of the campaign across traditional and social media. The launch is supported entirely through earned media (unpaid), including News UK, across titles such as The Sun, The Times and Talk Radio. The work will launch first in the United Kingdom followed swiftly by the United States and Canada.

Partnership between the three companies comes at a time when most major new sources are reporting on the issue. In addition, the United Nations has issued an open brief to the creative community asking for support in tackling misinformation surrounding COVID-19, the results of that contest will be announced at the end of April.

Infotagion has also launched a weekly podcast which will feature Damian Collins MP, former Chair of the Parliamentary Committee on Culture, Media and Sport and a member of the Iconic Labs team along with key media influencer guests. The first episode is out now and available on iTunes and Spotify and features John Quinlan, Damian Collins and Baroness Kidron.

Since the media launch of Infotagion there has been more than 87 pieces of individual news covered by the UK's major news outlets including the BBC, ITV, Daily Mail, radio and local and specialist news sites. 

The full list of media coverage surrounding Infotagion can be found here: https://www.iconiclabs.co.uk/infotagion-the-battle-against-disinformation/

In addition to this the group of supporters within governments and organisations around the world continues to grow and the full list is updated on the Infotagion website.

The company has been approached by a number of organisations including world leading Universities about using the Infotagion platform and data. The company looks forward to updating the market with the progress of these plans.

John Quinlan, Chief Executive Officer of Iconic Labs, said: ""We have made a very strong start with Infotagion. To receive such a response in such a short period of time just goes to show how important this service is to the public. The support has been unprecedented and the platform is growing day by day. The new podcast is the next stage of development and hopefully there will be much more to come. We plan to keep growing this platform and increasing the awareness of what Infotagion and Iconic Labs can achieve."

Infotagion

The Company announced a few weeks ago that, in partnership with Damian Collins MP, former Chair of the Parliamentary Committee on Culture, Media and Sport, it had established a service to counter the dissemination of incorrect information, in particular through social media, that relates to the Covid-19 pandemic and its related economic and social effects.

The core of the service is a website (www.infotagion.co.uk ) on which users post screenshots of information which they have received from social media or elsewhere. The submitted information is checked by a team organised by Mr Collins, which includes experts from, inter alia, the WHO and Parliament.

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

**ENDS**

 

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

 

Damon Heath

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

 

Iconic Labs

ir@iconiclabs.co.uk

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKKDBPBBKDBQB
Date   Source Headline
28th Mar 20247:00 amRNSInterim Results
11th Mar 202412:00 pmRNSHeads of Terms Signed
29th Feb 20247:00 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSSuspension of Trading
13th Feb 20242:08 pmRNSResult of AGM
7th Feb 20249:10 amRNSConversion of Notes and Allotment of Shares
19th Jan 20243:49 pmRNSNotice of AGM
4th Jan 20247:00 amRNSBoard Changes & Business and Strategy Update
29th Dec 20237:00 amRNSTotal Voting Rights
7th Dec 20238:53 amRNSConversion of Securities
4th Dec 20237:53 amRNSConversion of Securities
30th Nov 20237:00 amRNSTotal Voting Rights
17th Nov 202311:32 amRNSConversion of Securities
13th Nov 20238:40 amRNSConversion of Securities
2nd Nov 202310:35 amRNSConversion of Securities
31st Oct 20239:29 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSFull Year Results for the Year ended 30 June 2023
24th Oct 20235:31 pmRNSChange of Auditor
17th Oct 20237:51 amRNSConversion of Securities
13th Oct 202311:32 amRNSAnnouncement of the Completion of CVA
13th Oct 202311:30 amRNSConversion of Securities
29th Sep 20238:01 amRNSTotal Voting Rights
22nd Sep 20239:40 amRNSConversion of Securities
18th Sep 20236:27 pmRNSConversion of Notes – Replacement
18th Sep 20237:37 amRNSConversion of Securities
12th Sep 20238:45 amRNSStatement re CVA
4th Sep 202312:02 pmRNSConversion of Securities
31st Aug 20237:21 amRNSTotal Voting Rights
25th Aug 20234:49 pmRNSResult of AGM
18th Aug 20237:51 amRNSConversion of Securities
14th Aug 20237:59 amRNSIssue of Debt
8th Aug 20232:58 pmRNSPublication of a Prospectus
4th Aug 20234:19 pmRNSNotice of AGM
30th Jun 20239:12 amRNSTotal Voting Rights
2nd Jun 20231:20 pmRNSIssue of Equity
28th Apr 202310:35 amRNSTotal Voting Rights
12th Apr 20238:13 amRNSConversion of Securities
31st Mar 20233:11 pmRNSTotal Voting Rights
31st Mar 20231:59 pmRNSHalf-year Report
29th Mar 20232:05 pmRNSSecond Price Monitoring Extn
29th Mar 20232:00 pmRNSPrice Monitoring Extension
28th Mar 20237:42 amRNSConversion of Securities
27th Mar 202311:05 amRNSSecond Price Monitoring Extn
27th Mar 202311:00 amRNSPrice Monitoring Extension
22nd Mar 202311:48 amRNSSubscription of Convertible Notes
21st Mar 202311:05 amRNSSecond Price Monitoring Extn
21st Mar 202311:00 amRNSPrice Monitoring Extension
21st Mar 20239:05 amRNSSecond Price Monitoring Extn
21st Mar 20239:00 amRNSPrice Monitoring Extension
20th Mar 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.